ArticlePDF Available

SPECT patterns in probable Alzheimer’s disease

Authors:

Abstract and Figures

The primary objective of this study was to test hypotheses about the relationship between HMPAO-SPECT findings and probable Alzheimer’s disease (DAT) in a relatively large sample of patients diagnosed according to DSM-III-R. SPECT patterns of 20 controls and 116 DAT patients were investigated. Left and right frontal, temporal, parietal and occipital regions of the brain were rated as showing a hypoperfusion or not. A wide variety of patterns were found and these are described in detail below. In DAT patients, temporal and/or parietal regions were affected significantly more often (88%, p > 0.001) than frontal and/or occipital regions (70%). A bilateral temporoparietal pattern, which has been repeatedly reported as typical for DAT, was observed in 48% of DAT patients, but also in 25% of controls, and did not differentiate significantly between these two groups (p > 0.05). Conversely, more than three regions with hypoperfusion were observed significantly more often in DAT patients (48%, p < 0.01) than in controls (10%). In DAT patients, the number of regions with hypoperfusion correlated significantly with the score of the Mini Mental State Examination (MMSE, r = 0.33, p < 0.001). The frequency of at least one hypoperfusion was approximately equal in left and right hemispheres (77% vs. 73%, p = 0.2). The hypothesis that cognitive decline in DAT starts in the temporal regions was tested in 14 SPECT patterns showing only one region with hypoperfusion. In 12 of these patterns, a temporal region was in fact affected (p < 0.001). Whereas hypoperfusion in frontal areas was not accompanied by a significantly lower MMSE than when only temporoparietal regions were affected, MMSE scores were significantly lower when occipital regions were affected in addition to temporoparietal regions (p < 0.05). The clinical use of SPECT findings was tested in discriminating analyses with the MMSE and a delayed recall test as additional predictors of DAT. Whereas the MMSE and the delayed recall test differentiated significantly between DAT patients and controls, SPECT findings yielded no further differentiation. In conclusion, the theoretical and clinical implications of SPECT findings and their relationships to other physiological and psychological variables deserve further investigation.
Content may be subject to copyright.
Abstract The primary objective of this study was to
test hypotheses about the relationship between HMPAO-
SPECT findings and probable Alzheimer’s disease (DAT)
in a relatively large sample of patients diagnosed accord-
ing to DSM-III-R. SPECT patterns of 20 controls and
116 DAT patients were investigated. Left and right fron
tal,
temporal, parietal and occipital regions of the brain were
rated as showing a hypoperfusion or not. A wide variety
of patterns were found and these are described in detail
below. In DAT patients, temporal and/or parietal regions
were affected significantly more often (88%, p> 0.001)
than frontal and/or occipital regions (70%). A bilateral
temporoparietal pattern, which has been repeatedly re-
ported as typical for DAT, was observed in 48% of DAT
patients, but also in 25% of controls, and did not differen-
tiate significantly between these two groups (p> 0.05).
Conversely, more than three regions with hypoperfusion
were observed significantly more often in DAT patients
(48%, p< 0.01) than in controls (10%). In DAT patients,
the number of regions with hypoperfusion correlated sig-
nificantly with the score of the Mini Mental State Exami-
nation (MMSE, r= 0.33, p< 0.001). The frequency of at
least one hypoperfusion was approximately equal in left
and right hemispheres (77% vs. 73%, p= 0.2). The hy-
pothesis that cognitive decline in DAT starts in the tempo-
ral regions was tested in 14 SPECT patterns showing only
one region with hypoperfusion. In 12 of these patterns, a
temporal region was in fact affected (p< 0.001). Whereas
hypoperfusion in frontal areas was not accompanied by a
significantly lower MMSE than when only temporoparietal
regions were affected, MMSE scores were significantly
lower when occipital regions were affected in addition to
temporoparietal regions (p< 0.05). The clinical use of
SPECT findings was tested in discriminating analyses with
the MMSE and a delayed recall test as additional predictors
of DAT. Whereas the MMSE and the delayed recall test
differentiated significantly between DAT patients and con-
trols, SPECT findings yielded no further differentiation.
In conclusion, the theoretical and clinical implications of
SPECT findings and their relationships to other physio-
logi
cal
and psychological variables deserve further inves-
tigation.
Key words HMPAO-SPECT · Alzheimer’s disease ·
Hypoperfusion
Introduction
Probable dementia of the Alzheimer type (DAT) is asso-
ciated with changes in regional cerebral blood flow that
can be detected using single photon emission computer
tomography (SPECT) (Gemmel et al. 1987, Burns et al.
1989, Geany et al. 1990, Montaldi et al. 1990, Habert et
al. 1991). The value of SPECT findings in the diagnosis
of DAT is still a matter of debate. For instance, Poremba
(1993) argues that there are no DAT-specific biological
markers to date, whereas Volles (1991) notes that functional
imaging such as PET and SPECT may identify DAT even
in early stages of the disease when the CCT is still nor-
mal. The different views may be explained by the hetero-
geneity of findings which is itself probably due to differ-
ences in methods and samples. The samples especially vary
in the severity of dementia, and the sizes of the groups in-
vestigated often seem rather low. The finding probably
noted most often in DAT patients is bilateral temporopari-
etal hypoperfusion. This finding is confirmed by some
early PET studies (Frackowiak et al. 1981, McGeer et al.
1986). However, unilateral hypometabolism may also oc-
cur, especially in early DAT (Salmon and Franck 1989)
H. Müller · H.-J. Möller · A. Stippel · M. Fric ·
F. Grünwald · G. Laux · E. Klemm · H.-J. Biersack
SPECT patterns in probable Alzheimer’s disease
Eur Arch Psychiatry Clin Neurosci (1999) 249:190–196 © Steinkopff Verlag 1999
Received: 3 December 1998 / Accepted: 1 April 1999
ORIGINAL PAPER
H. Müller · A. Stippel
Psychiatric Department, Bonn University, Germany
M. Fric · G. Laux
Gabersee Regional Hospital, Wasserburg/Inn, Germany
F. Grünwald · E. Klemm · H.-J. Biersack
Department of Nuclear Medicine, Bonn University, Germany
Prof. H.-J. Möller ()
Psychiatric Hospital, Nussbaumstr. 7, D-80336 Munich, Germany
Tel.: +49-89-5160-5501, Fax: +49-89-5160-5522
and bilateral temporoparietal hypoperfusion is also found
in Parkinson’s disease with dementia (Kuhl et al. 1984,
Holman et al. 1992, Salmon et al. 1993), vascular demen-
tia (Kuwabara et al. 1990), and Creutzfeld-Jakob disease
(Friedland et al. 1984). Recent studies show that bilateral
temporoparietal hypoperfusion (with or without additional
defects) characterises approximately 50–65% of DAT pa-
tients (Holman et al. 1992, Horn et al. 1995). Thus, the
sensitivity of this hypoperfusion pattern seems low, but
the specificity seems high, if Parkinson’s disease with de-
mentia can be excluded. Moreover, it seems unlikely that
a certain pattern of hypoperfusion is characteristic for all
stages of DAT.
Eberling et al. (1992) suggested – as many authors have
done previously – that the temporal lobes are the first neo-
cortical regions affected in DAT. Eberling’s group ob-
served temporal changes in mild and moderate DAT,
whereas decline was only seen in other regions in moder-
ate DAT. Wolfe et al. (1995) reported that the temporal lobe
regional cerebral blood flow ratio – but not parietal or
frontal ratios – predicts cognitive decline over a longitu-
dinal follow-up. In criticism, it must be mentioned that
Wolfe et al. (1995) used the ratio of region of interest to
occipital cortex, and assumed the occipital cortex to be
“relatively unaffected” by DAT. This assumption seems
questionable, at least at later stages of DAT. Nevertheless,
current evidence suggests that the role of the temporal
lobes in the first stages of DAT deserves further investiga-
tion.
Besides the inherent methodological difficulties already
mentioned, the evaluation of previous findings is compli-
cated by the fact that most studies describe the observed
perfusion patterns incompletely. The purpose of the cur-
rent study is to evaluate hypoperfusion patterns in a rela-
tively large sample of DAT patients, to describe them ex-
haustively and to test them in comparison to SPECT pat-
terns of a control group of patients diagnosed as “normal”.
To our knowledge, this is the first study with more than
100 DAT patients. A detailed evaluation of hypoperfusion
patterns that show only one region with hypoperfusion
(“isolated patterns”) describes the beginning of cortical
deterioration in DAT. A predominant affection of tempo-
ral lobes in these isolated patterns was expected. A critical
evaluation of the clinical value of SPECT patterns in the
diagnosis of DAT leads to the question whether SPECT
findings supply additional information compared to other
well-established diagnostic techniques. We, therefore, per-
formed discriminating analyses that tested whether SPECT
findings enhance discrimination between controls and DAT
patients beyond the level reached by evaluation of the
Mini Mental State Examination (MMSE, Folstein et al.
1975) and two delayed verbal memory test. Delayed mem-
ory tests are known to be sensitive indicators of even mild
DAT (Welsh et al. 1992).
Method
Diagnosis
First of all, thorough psychiatric and neurological examinations were
conducted. Furthermore, the MMSE (Folstein et al. 1975), Hachin-
ski Scale (Hachinski et al. 1975) and an extensive neuropsycho-
logical test battery were performed. DSM-III-R criteria (American
Psychiatric Association 1987) were employed for diagnosis. Cause
s
of dementia other than DAT were excluded by laboratory-chemical
analyses, CCT/MRT, EEG, and extracranial and transcranial Dop-
pler sonography. Patients with a Hachinski score greater than 4 or
more than two lacunal infarctions in CCT or MRT were excluded
under a probable diagnosis of a vascular or a mixed-type dementia.
HMPAO-SPECT
Interictal brain SPECT imaging was performed 30 to 120 min after
injection of 555-740 MBq
99m
Tc-HMPAO. Four different types
of SPECT acquisition systems were used: three different rotating
gamma cameras: APEX 409 (Elscint, single head, A); DYNA-SCAN
(Picker, dual-head, B); Genesys (ADAC, single-head, C). With an
acquisition time of 20–30 min, 60 (A) or 64 (B and C) projections
were acquired with a 64*64 matrix. A ring system has been used
since 1992: CERASPECT system (Digital Scintigraphic Inc., D).
The system works with three collimators rotating within a single
crystal system iodide ring detector and acquires three views from
three angles simultaneously. The acquisition time was 30 min. One
hundred and twenty projections were acquired uisng a 512*64 ma-
trix. Coronal, sagittal and transaxial (parallel to the orbitomeatel
line) slices were calculated from the original transaxial slices and
summed in order to obtain two (A/B/C) or four (D) pixel thick
slices. Additionally, “thin” slices (one pixel thick, parallel to the
long axis of the temporal lobes) were calculated for evaluation of
the temporal lobes. Two experienced nuclear medicine physicians
who were blind to diagnosis and neuropsychological test results
rated the findings. Eight regions of interest were defined: left and
right frontal, temporal, parietal and occipital lobes, and it was eval-
uated whether these regions showed a hypoperfusion or not.
Assessment of cognitive performance
Although many neuropsychological tests were performed in this
study, this article is restricted to the evaluation of the MMSE and
two delayed word tests. Delayed word recall has been proven to be
extremely sensitive in the detection of mild cases of DAT (Welsh
et al. 1992). Two tests of delayed word recall of varying difficulty
were employed in our sample. Thirty-five patients who seemed less
handicapped at an initial interview heard and recalled a 15-item
word list five times. A second 15-item list was then given and re-
called. Afterwards, patients were asked to recall the first word list
without additional presentation. After a 30 min interval, the first
word list had to be recalled a seventh time and the number of cor-
rectly reproduced words was scored (delayed word recall of 15 items,
DWR15). Fifty-nine patients who seemed more handicapped un-
derwent a similar procedure, but with an eight-item word list. This
list was presented and recalled five times and then had to be re-
called after a 30 min interval (DWR8). Although it is a method-
ological weakness of this study that not both delayed recall tests
(or at least the same one) were employed for all patients, the use of
different lists and methods seemed clinically useful at the time of
testing in order to adjust the testing procedure according to the
severity of impairment.
Hypotheses
Review of the literature led to formulation of the following hypothe-
ses: 1. A bilateral temporoparietal pattern of hypoperfusion should
191
192
significantly differentiate between DAT patients and controls. 2. In
DAT patients, temporal and parietal cortex should be affected more
frequently than frontal and occipital cortex, and the frequency of
affection of left and right hemispheres should be approximately
equal.
3. In DAT patients, more regions of the brain should show
hypoperfusion than in controls. 4. If SPECT shows only one re-
gion with hypoperfusion, then this region is expected to be tempo-
ral since it is assumed that this is the first cortical area affected. 5.
If SPECT is clinically useful, then the discrimination between DAT
patients and controls should improve after inclusion of SPECT find-
ings in discriminating analyses with MMSE, DWR8 and DWR15
as predictors of diagnosis.
Sample
The sample was recruited in the memory clinic of the psychiatric
department of Bonn university hospital. One hundred and thirty-
six patients had undergone a HMPAO-SPECT and were diagnosed
according to the criteria of DSM-III-R as suffering from DAT
(116) or not suffering from dementia (20) (Table 1). The controls
of the latter group, however, reported at least some cognitive com-
plaints – typically memory problems – which were the reason for
their examination at the memory clinic.
Statistics
First of all, a complete description of the observed hypoperfusion
patterns in the 116 DAT patients and the 20 controls is given. Thus,
the data may be used to test hypotheses other than the ones tested
here or may be combined with data sets from other studies. Frequen-
cies of patterns were tested with the binomial test. Associations be-
tween patterns, and between patterns and diagnoses, were tested
with the Pearson chi
2
-test and sometimes described with phi val-
ues. MMSE scores in different groups were tested with the t-test
for independent samples and the predictive value of SPECT find-
ings was evaluated by discriminating analyses using MMSE and
delayed free recall as additional predictors. All statistical analyses
were performed with SAS 6.03 for personal computers.
Results
The following SPECT patterns were observed in the
116 DAT patients (Table 2). There were 16 patterns which
were significantly more frequent than would be expected
by chance. The multiple use of the binomial test in 50 pat-
terns infers the risk that some of the “significantly” frequent
patterns are significant by chance. Therefore, we would
only like to comment on the patterns with a frequency of
at least five before we draw some general conclusions. In
8.6% of the DAT patients, no hypoperfusion was detected.
In 6.9%, only the left temporal lobe seemed to be affected.
In 6.0%, all regions except the frontal ones showed hy-
poperfusion. In 4.3%, only the parietal and the occipital
Table 1 Sample description
DAT Control
N 116 20
Age (mean ± std. dev.) 66 ± 9 56 ± 10
Sex (female/male) 60/56 12/8
MMSE (mean ± std. dev.) 19.9 ± 5.4 28.8 ± 1.2
Table 2 Observed frequencies of SPECT patterns in 116 DAT pa-
tients
Pattern
a
Frequency Relative fre- p< 0.01
b
quency (%)
00000000 10 8.6 *
00001000 1 0.9
00001010 3 2.6 *
00001111 5 4.3 *
00010000 4 3.4 *
00010001 2 1.7
00010100 2 1.7
00011010 1 0.9
00011100 1 0.9
00011111 1 0.9
00100000 8 6.9 *
00100010 1 0.9
00101010 1 0.9
00101100 1 0.9
00101111 5 4.3 *
00110000 3 2.6 *
00110011 1 0.9
00110101 1 0.9
00111011 1 0.9
00111100 5 4.3 *
00111111 7 6.0 *
01000100 3 2.6 *
01010000 2 1.7
01010100 3 2.6 *
01010101 1 0.9
01011111 3 2.6 *
01100000 1 0.9
01110000 1 0.9
01110101 1 0.9
01111000 1 0.9
01111100 2 1.7
10000000 1 0.9
10100000 1 0.9
10100100 1 0.9
10100101 1 0.9
10101010 5 4.3 *
10101111 1 0.9
10110000 1 0.9
10111100 1 0.9
11000000 3 2.6 *
11001000 2 1.7
11001100 1 0.9
11001111 3 2.6 *
11010000 2 1.7
11011101 1 0.9
11100000 1 0.9
11110000 2 1.7
11111000 1 0.9
11111100 5 4.3 *
11111111 1 0.9
a
0 denotes normal perfusion, 1 hypoperfusion; the strings are in
the sequence left frontal lobe – right frontal lobe – left temporal
lobe – right temporal lobe – left parietal lobe – right parietal lobe –
left occipital lobe – right occipital lobe
b
binomial test with equal prior probability of each pattern =
1/256
regions were affected. In 4.3%, a similar pattern was ob-
served: all regions except the frontal ones and the right
temporal lobe seemed to be affected. In a further 4.3% of
the DAT patients, only the temporal and parietal regions
were affected. In a further 4.3%, all frontal, temporal and
parietal regions showed hypoperfusion, whereas the oc-
cipital regions were spared. Thus, the predominant impres-
sion from Table 2 is that there is a wide variety of SPECT
patterns in DAT. Of course, the patterns result from dif-
ferent stages of the disease and are not error free. How-
ever, it seems unlikely that even for different stages of
DAT “the” typical pattern arises. The frequency of invol
ve-
ment of left and right hemispheres was approximately
equal (77% and 73% respectively, p= 0.2, binomial test).
Table 3 shows the patterns observed in the 20 con-
trols.
Of course, the relative frequencies given in Table 3 are
rough estimates, with N being only 20. For this reason, we
do not want to comment on the patterns in detail but would
just like to mention that only 25% of the controls showed
a SPECT pattern without any hypoperfusion.
Is bilateral temporoparietal hypoperfusion DAT-sensitive
and -specific?
One problem with the term “bilateral temporoparietal hy-
poperfusion” is that it is not clear exactly which patterns
are being described with this expression. In fact, different
authors using this term assume different patterns and it is
difficult, if not impossible, to decide which definition is
the most appropriate one. We, therefore, used different de-
finitions ranging from extremely narrow to extremely broad
and report the observed frequencies for DAT patients and
controls in Table 4.
Table 4 shows that the extreme definitions are obviously
not appropriate. Although we investigated only 20 con-
trols – and, therefore, the chi
2
-test for significant associa-
tion may seem somewhat hard – this result shows that the
association between bilateral temporoparietal hypoperfu-
sion and DAT is at least not a very close one.
Another implication of the hypothesis of bilateral tem-
poroparietal hypoperfusion in DAT patients is that tempo-
ral and parietal regions of the brain should be affected more
often than frontal and occipital regions. In fact, 88% of
our DAT patients showed at least one temporal or parietal
hypoperfusion, whereas 70% showed frontal and/or occipi-
tal hypoperfusions. A binomial test showed that the fre-
quency of temporal and/or parietal affection was signifi-
cantly higher (p< 0.001) than the 70% observed in frontal
and/or occipital regions. Nevertheless, the observed dif-
ference of only 18% again suggests that at least in later
stages of DAT hypoperfusions are often not restricted to
the temporoparietal regions.
If DAT cannot be characterised easily by a certain pat-
tern of hypoperfusion, it could theoretically be assumed that
the amount of hypoperfusion is perhaps decisive. Since
only 10% of the controls showed hypoperfusions in more
than three regions, this cut-off point was also used in DAT
patients. 48% of the DAT patients had SPECT patterns
with hypoperfusions in more than three regions and this
criterion proved to be significantly associated with diag-
nosis (p< 0.01, chi
2
-test). Fig.1 shows the mean MMSE
for the number of regions with hypoperfusion in DAT pa-
tients.
193
Table 3 Observed frequencies of SPECT patterns in 20 controls
Pattern
a
Frequency Relative frequency (%)
00000000 5 25
00000100 2 10
00010000 1 5
00010100 2 10
00011100 1 5
00100000 1 5
00101000 2 10
00110000 1 5
00111100 1 5
01100000 1 5
01110000 1 5
10100000 1 5
11110011 1 5
a
0 denotes normal perfusion, 1 hypoperfusion; the strings are in
the sequence left frontal lobe – right frontal lobe – left temporal
lobe – right temporal lobe – left parietal lobe – right parietal lobe –
left occipital lobe – right occipital lobe
Table 4 Observed frequencies
of bilateral temporoparietal hy-
poperfusion in 116 DAT pa-
tients and 20 controls for dif-
ferent definitions of bilateral
temporoparietal hypoperfusion
a
l = left, r = right, f = frontal,
t = temporal, p = parietal,
o = occipital
b
0 = normal perfusion, 1 = hy-
poperfusion, X = normal or
hypoperfusion
Definition
a
Classification Patterns
b
Relative frequency (%) p
Chi
2
-
DAT patients Controls test
lt and rt and Extremely 00111100 4 5 0.89
lp and rp and narrow
not (lf or rf or
lo or ro)
lt and rt and Narrow XX1111XX 18 5 0.14
lp and rp
(lt and rt) or Broad XX1X1XXX 48 25 0.053
(lp and rp) XXX1X1XX
lt or rt or lp or Extremely XX1XXXXX 87 75 0.12
rp broad XXX1XXXX
XXXX1XXX
XXXXX1XX
There is a significant linear trend for the MMSE score to
decrease with the number of regions with hypoperfusion
(r= 33, p < 0.01).
To summarise, the data from this study show that the
number of regions with hypoperfusion is more closely as-
sociated with DAT than the existence of any bilateral tem-
poroparietal pattern. The severity of DAT as assessed with
the MMSE is also significantly but not very closely re-
lated to the number of regions with hypoperfusions. Al-
though these data suggest that the importance of bilateral
temporoparietal hypoperfusion in DAT may have been
overemphasised in the past, the importance of pattern
analyses in general should not be renounced prematurely.
The next section describes some more detailed analyses
of the observed patterns.
Does DAT start in the temporal regions?
The hypothesis that the cortical starting point of DAT is the
temporal region is old, and in the meantime some data –
including SPECT findings – have been acquired which
seem to support this hypothesis (Eberling et al. 1992). One
implication of this hypothesis that can be easily tested
with the data from this study is that, if there is only one re-
gion with hypoperfusion, this should be a temporal one.
Fourteen of our DAT patients showed only one region
with hypoperfusion; the left temporal lobe was affected
eight times and the right temporal lobe four times, whereas
the left frontal and left parietal lobes were each affected
only once. The probability of the observed accumulation in
the temporal regions is p< 0.001 (binomial test with the
assumption that hypoperfusions in all regions were equally
probable = 1/8). This result strongly supports the hypoth
e-
sis that the temporal region is usually the first one af-
fected. Nevertheless, it must be mentioned that in the four
controls who showed hypoperfusion in only one region,
the temporal region was affected in two cases (and the
right parietal region in two cases). Although the low N of
controls necessitates care, this observation might suggest
that the temporal regions may be especially vulnera
ble in
general and not only for DAT. Although the left tem
poral
lobe was affected twice as often as the right temporal lobe
in this sample, this difference is not statistically signifi-
cant with the low number of patterns showing only one re-
gion with hypoperfusion.
Relationships between hypoperfusions in different areas
Table 5 shows phi coefficients for the associations between
each pair of brain regions when 2*2 tables of the respec-
tive regions are statistically analysed. In this case, phi co-
efficients are comparable to correlations and can have val-
ues between – 1 and 1.
Especially the parieto-occipital region shows high and
significant associations. A closer look at this region shows
that if the left occipital lobe is affected, then in 95% of
cases in this study the left parietal region is also affected.
The respective relative conditional frequency for the right
occipital region and the right parietal region is 89%. A
194
Fig.1 Means and standard deviations of the Mini Mental State
Examination (MMSE, Folstein et al. 1975) for the number of re-
gions with hypoperfusion in SPECT
Table 5 Association (phi co-
efficients) between hypoperfu-
sions in different brain regions
of N = 116 DAT patients
*P< 0.05, chi
2
-test
**P< 0.01, chi
2
-test
***P< 0.001, chi
2
-test
fr = frontal, te = temporal, pa =
parietal, oc = occipital/l = left,
r = right
fr/l fr/r te/l te/r pa/l pa/r oc/l
fr/r 0.41***
te/l 0.12 –0.18*
te/r –0.10 0.23* 0.14
pa/l 0.14 –0.01 0.21* 0.07
pa/r –0.05 0.17 0.09 0.26** 0.50***
oc/l –0.06 –0.25** 0.09 –0.15 0.63*** 0.26**
oc/r –0.13 –0.08 0.02 0.11 0.38*** 0.53*** 0.65***
plausible explanation for these associations is that after
affection of the parietal regions, the ipsilateral occipital
regions are affected next. All directly neighboured regions
– ipsilateral and contralateral – with exception of the left
frontal and temporal region and the left and right tempo-
ral region show significant associations. although these
associations are clearly lower than in the parieto-occipital
regions.
An interesting question is whether the additional in-
volvement of the occipital region is accompanied by fur-
ther functional decline. We, therefore, compared the MMSE
scores of patients who showed only temporoparietal af-
fection with those who also showed occipital affection. In
fact, the first group had a significantly higher mean MMSE
score (22.1) than the second group (18.3, p< 0.05, t-test).
A similar analysis comparing the frontal with the tem-
poroparietal region showed no significant difference. Thus,
hypoperfusion in the occipital region seems to occur pre-
dominantly after affection of the parietal region and is ac-
companied by further cognitive decline.
Do SPECT data contribute to the accuracy of diagnosis?
Thirteen of our controls and 22 of our DAT patients were
tested with the MMSE and the more difficult delayed word
recall test (DWR15). We performed discriminating analy-
ses with MMSE and DWR15 as predictors. These vari-
ables discriminated significantly (p< 0.05) between diag-
noses and classified 95% of DAT patients and 92% of con-
trols correctly. Inclusion of the number of brain areas
showing hypoperfusion as an additional predictor did not
alter this result at all. Five of the controls and 54 of the
DAT patients were tested with the MMSE and the easier
delayed word recall test (DWR8). MMSE and DWR8 dis-
criminated again significantly (p< 0.05) between diag-
noses and classified 87% of DAT patients and 100% of
controls correctly. Again, additional inclusion of the num-
ber of brain areas showing hypoperfusion did not improve
classification. Thus, using only the MMSE and a delayed
word recall test, good discrimination of diagnoses could
be reached and there was no case in which this discrimi-
nation could be improved by taking the best discriminat-
ing SPECT variable into account. Although the N of con-
trols is low, and therefore caution is necessary, in these data,
SPECT findings are clearly outperformed by variables of
cognitive function in their ability to differentiate between
controls and DAT patients.
Discussion
SPECT patterns observed in 20 controls and 116 DAT pa-
tients were evaluated. Although the temporal and parietal
region showed hypoperfusion more frequently in DAT pa-
tients than the frontal and occipital region, bilateral tem-
poroparietal hypoperfusion seems less characteristic for
DAT than previously suggested. In these data, none of four
different bilateral temporoparietal patterns was significantly
associated with diagnosis. However, the most appropriate
definition of bilateral temporoparietal hypoperfusion (bi-
lateral temporal and/or parietal hypoperfusion with or with-
out additional defects) led to patterns that only just missed
significant association with diagnosis (p= 0.053). More-
over, the sample of controls was not large and is conspic-
uous in that the control patients – although finally diag-
nosed as “normal” – visited our memory clinic. Therefore,
we feel sure that with a larger and/or less conspicuous sam-
ple of controls, a significant association between diagno-
sis and presence of bilateral temporoparietal hypoperfu-
sion could be demonstrated. Nevertheless, a significant
association does not mean that there is a close relationship,
and in keeping with recent work (Holman et al. 1992,
Horn et al. 1995), these data show that broadly defined bi-
lateral temporoparietal hypoperfusion is found in only ap-
proximately 48% of DAT patients and also approximately
25% of controls with cognitive problems. In looking for
an alternative SPECT indicator of DAT, the amount of hy-
poperfusions as indicated by the number of brain regions
showing hypoperfusion was evaluated. This indicator –
more than three regions with hypoperfusion – was signif-
icantly associated with diagnosis, and was more DAT-spe-
cific in this sample in that only 10% of the controls
showed this feature. Moreover, in DAT patients the num-
ber of brain regions with hypoperfusion correlated signif-
icantly with the severity of dementia as measured by the
MMSE. Nevertheless, further research is needed to decide
whether this purely quantitative consideration of SPECT
data, which completely ignores the location of hypoperfu-
sion, is really an alternative or supplementation to other
approaches.
In keeping with earlier publications (e.g. Eberling et al.
1992), the data from this study suggest that the cortical
decline in DAT usually begins in the temporal regions: the
temporal lobes were affected in 12 of the 14 cases which
had hypoperfusion in only one region. If the occipital lobe
was affected, then the ipsilateral parietal lobe was also af-
fected in approximately 90% of cases. Hypoperfusion in
the occipital lobe yielded significantly lower MMSE scores
than in the temporoparietal region. Thus, in DAT final
cortical involvement seems to extend usually from the
parietal to the occipital lobe, accompanied by further cog-
nitive impairment. Conversely, involvement of the frontal
lobe did not significantly influence the MMSE score com-
pared to the level that was observed with only tem-
poroparietal affection.
DAT patients and controls could be well discriminated
by the use of the MMSE and two delayed verbal recall tests
(correct classification in about 90% of the cases). Addi-
tional inclusion of SPECT findings did not improve clas-
sification in any single case. Therefore, SPECT findings
seem to be less useful than is sometimes suggested for the
differentiation between controls and DAT patients. To the
best of our knowledge, the performance of SPECT data in
the differentiation of diagnoses has not yet been tested in
comparison with other diagnostic tools.
To summarise, our results are not surprising if earlier
and recent literature is evaluated critically. The diagnosis
195
196
of DAT remains primarily a clinical one, and the relation-
ship between DAT and SPECT patterns is complex. Nev-
ertheless, SPECT patterns contribute importantly to the de-
scription of changes in cerebral perfusion that are caused
by DAT and other demential diseases. In this respect,
HMPAO-SPECT can contribute valuable and clinically rel-
evant information to other imaging approaches (Hampel
et al. 1997) in the field of the aetiopathology and diagno-
sis of dementia.
References
American Psychiatric Association (1987) Diagnostic and statistical
manual of mental disorders (DSM-III-R) 3rd edn, Washington
Burns A, Philpot M, Costa D, Ell P, Levy R (1989) The investiga-
tion of Alzheimer’s disease with single photon emission to-
mography. J Neurol Neurosurg Psychiatry 52:248–253
Eberling JL, Jagust WJ, Reed BR, Baker MG (1992) Reduced tem-
poral lobe blood flow in Alzheimer’s disease. Neurobiol Aging
13:483–491
Folstein MF, Folstein SE, McHugh PR (1975) “Mini Mental
State”. A practical method for grading the cognitive state of pa-
tients for the clinician. J Psychiat Res 12:189–198
Frackowiak RSJ, Pozzili C, Legg NJ, et al. (1981) Regional cerebral
oxygen supply and utilization in dementia: a clinical and phys-
iological study with oxygen-15 and positron tomography. Brain
104:753–778
Friedland RP, Prusiner S, Jagust W, Budinger TF (1984) Bitempo-
ral hypometabolism in Creutzfeld-Jakob disease: positron emis-
sion tomography with
18
F-2-fluorodeoxyglucose. J Comput As-
sist Tomogr 8:978–981
Friedland RP, Brun A, Budinger TF (1985) Pathological and
positron
emission tomographic correlations in Alzheimer’s dis-
ease. Lancet 1:228
Geaney D, Soper N, Shepstone B, Cowen P (1990) The effect of
central cholinergic stimulation on regional cerebral blood flow
in Alzheimer’s disease studied by single photon emission to-
mography. Lancet 335:1484–1487
Gemmel H, Sharp O, Besson J (1987) Differential diagnosis in de-
mentia using the cerebral blood flow agent 99m TC HMPAO:
a Spect study. J Comp Assis Tomog 11:398–402
Grünwald F, Horn R, Rieker O, Klemm E, Menzel C, Möller H-J,
Biersack H-J (1993) HMPAO-SPECT bei Demenz vom Alz-
heimer-Typ und Major Depression mit mnestischen Störungen
[HMPAO-SPECT in dementia of the Alzheimer type and Ma-
jor Depression with memory impairment]. Nuklearmedizin 32:
128–133
Habert M, Spampinato U, Mas J, et al. (1991) A comparative tech-
netium 99m hexamethylpropylene amine oxime SPECT study
in different types of dementia. Europ J Nuclear Med 18:3–11
Hachinski VC, Iliff LD, Chiak E, et al. (1975) Cerebral blood flow
in dementia. Arch Neurol 32:632–637
Hampel H, Padberg F, Kötter HU, Teipel SJ, Ehrhardt T, Hegerl
U, Stübner S, Möller H-J (1997) Diagnostik und Therapie der
Demenz vom Alzheimer-Typ. Münch med Wschr 139:35–41
Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A (1992)
The scintigraphic appearance of Alzheimer’s disease: a prospec-
tive study using Technetium-99m-HMPAO SPECT. The Jour-
nal of Nuclear Medicine 33:181–185
Horn R, Grünwald F, Rieker O, Klemm E, Menzel C, Möller H-J,
Biersack H-J (1995) HMPAO-SPECT in memory disorders. In
Grünwald F, Kasper S, Biersack H-J, Möller H-J (eds) Brain
SPECT imaging in psychiatry. de Gruyter, Berlin, pp 97–112
Kuhl DE, Metter EJ, Riege WH (1984) Pattern of local cerebral
utilization determined in Parkinson’s disease by the [
18
F]fluo-
rodeoxyglucose method. Ann Neurol 15:419–424
Kuwabara Y, Ichiya Y, Otsuka M, et al. (1990) Differential diag-
nosis of bilateral parietal abnormalities in I-123 IMP SPECT
imaging. Clin Nucl Med 15:893–899
McGeer PL, Kamo H, Harrop R, et al. (1986) Comparison of PET,
MRI, and CT with pathology in a proven case of Alzheimer’s
disease. Neurology 36:1569–1574
Montaldi D, Brooks D, McColl J, Wyper D, Patterson J, Barron E,
McCulloch J (1990) Measurements of regional cerebral blood
flow and cognitive performance in Alzheimer’s disease. J Neu-
rol Neurosurg Psychiatry 53:33–38
Poremba M (1993) Demenzen [Dementias]. In: Brandt T, Dichgans
J, Diener HC (eds) Therapie und Verlauf neurologischer Er-
krankungen [Therapy and course of neurologic diseases]. Kohl
-
hammer, Stuttgart, pp 890–911
Salmon E, Frack G (1989) Positron emission tomographic study in
Alzheimer’s disease and Pick’s disease. Arch Gerontol Geriatr
Suppl 1:241–247
Salmon E, Sadzot B, Maquet P, Degueldre C, Lemaire C, Rigo P,
Comar D, Franck G (1993) Differential diagnosis of Alzhei-
mer’s disease with PET. The Journal of Nuclear Medicine 35:
391–398
Volles E (1991) Sogenannte degenerative Krankheiten. In: Fröscher
W (ed) Neurologie. de Gruyter, Berlin, pp 347–368
Welsh KA, Butters N, Hughs JP, Mohs RC, Heyman A (1992) De-
tection and staging of dementia in Alzheimer’s disease. Arch
Neurol 49:448–452
Wolfe N, Reed BR, Eberling JL, Jagust WJ (1995) Temporal lobe
perfusion on single photon emission computed tomography pre-
dicts the rate of cognitive decline in Alzheimer’s disease. Arch
Neurol 52:257–262
... Neuropsychological studies revealed that DLB patients have prominent functional deficits in attention, visual percep- tion, working memory, and frontal executive function compared to AD [65][66][67]. The occipital dominant impairment observed in DLB patients could explain the deficits in visual attention and visual perception because visual information flows from the occipital cortex to higher cognitive areas such as the VAN and DAN [68]. In support of this argument, there is a previous finding that the administration of AchEI, which increases Ach in the brain, recovered global cognitive function and occipital hypoperfusion in DLB patients [69,70]. ...
Article
Full-text available
Background: Dementia with Lewy bodies (DLB) is characterized by progressive cognitive decline, fluctuating cognition, visual hallucinations, rapid eye movement sleep behavior disorder, and parkinsonism. DLB is the second most common type of degenerative dementia of all dementia cases. However, DLB, particularly in the early stage, is underdiagnosed and sometimes misdiagnosed with other types of dementia. Thus, it is of great interest investigating neurophysiological markers of DLB. Method: We introduced exact low-resolution brain electromagnetic tomography (eLORETA)-independent component analysis (ICA) to assess activities of 5 electroencephalography (EEG) resting-state networks (RSNs) in 41 drug-free DLB patients. Results: Compared to 80 healthy controls, DLB patients had significantly decreased activities in occipital visual and sensorimotor networks, where DLB patients and healthy controls showed no age dependences in all EEG-RSN activities. Also, we found correlations between all EEG-RSN activities and DLB symptoms. Specifically, decreased occipital α activity showed correlations with worse brain functions related to attention/concentration, visuospatial discrimination, and global cognition. Enhanced visual perception network activity correlated with milder levels of depression and anxiety. Enhanced self-referential network activity correlated with milder levels of depression. Enhanced memory perception network activity correlated with better semantic memory, visuospatial discrimination function, and global cognitive function as well as with severer visual hallucination. In addition, decreased sensorimotor network activity correlated with a better semantic memory. Conclusion: These results indicate that eLORETA-ICA can detect EEG-RSN activity alterations in DLB related to symptoms. Therefore, eLORETA-ICA with EEG data can be a useful noninvasive tool for sensitive detection of EEG-RSN activity changes characteristic of DLB and for understanding the neurophysiological mechanisms underlying this disease.
... In this study a significant relationship between the decrease in the perfusion of the different cerebral lobes in the brain (temporal and frontal lobes and the left parietal lobe) with the decrease in the initial MMSe scores was found (table 2). in 116 patients with aD Müller et al. reported a significant linear trend with decreasing MMSE scores with respect to decrease in cerebral perfusion involving certain brain areas [31]. ...
Article
Full-text available
The relationship between the initial mini-mental state examination (MMSE) score and cerebral perfusion was evaluated in patients with Alzheimer's disease (AD). In the study single photon emission computed tomography (SPECT) images of the brains of 40 AD patients were compared with the brain scans of 10 healthy controls. Each patient underwent MMSE analysis at initial evaluation as well as Tc-99 m hexamethylpropyleneamine oxine (HMPAO) brain SPECT. The patients were followed up for at least 42 months. The regional cerebral blood flow (rCBF) values for patients were found to be significantly decreased for all cerebral lobes compared to the control subjects and p-values were calculated to be less than 0.001 except for occipital lobes. The most statistically significant correlation between the MMSE scores and rCBF values was determined for the left temporal lobe (p < 0.0001). A significant correlation was also found for the right temporal lobe (p < 0.005). A minimal statistically significant correlation was found for the frontal lobes and the left parietal lobe (p < 0.05). The overall cerebral perfusion was decreased except in the occipital lobes in AD cases with low initial MMSE scores and there was a significant relationship between the decrease in perfusion of the temporal/frontal lobes and the left parietal lobe with the decrease in the initial MMSE scores. The most significant relationship between the decrease in the initial MMSE scores and the rCBF values was determined for the temporal lobes (especially for the left temporal lobe). It was also found that the left frontal lobe was affected from the beginning of the disease.
Article
Full-text available
Single-photon emission-computed tomography (SPECT) may potentially contribute to the diagnostic work up of patients with neurodegenerative dementia. This systematic review aims to establish the diagnostic utility of (99m)Tc-hexamethylpropyleneamine ((99m)Tc-HMPAO) and (99m)Tc-ethylcysteine dimer SPECT in distinguishing between Alzheimer's disease (AD) and frontotemporal dementia (FTD), AD and vascular dementia (VD), AD and dementia with Lewy bodies (DLB), and AD and normal controls (NC). We searched MEDLINE and Embase databases via OVID for articles from January 1985 to May 2012 and identified additional studies from reviews and references. Of 755 studies, 49 studies met the inclusion and exclusion criteria for this systematic review; AD versus FTD (n = 13), AD versus VD (n = 18), AD versus DLB (n = 5), and AD versus NC (n = 18). We compiled relevant data and graded the studies with an internal and external validity criteria checklist. We pooled the studies with a clinical diagnosis and those using (99m)Tc-HMPAO SPECT in a meta-analysis, calculating the pooled weighted sensitivity, specificity, likelihood ratios, and diagnostic odds ratios using DerSimonian-Laird random-effects model. The pooled weighted sensitivity and specificity of (99m)Tc-HMPAO-SPECT in distinguishing clinically diagnosed AD from FTD are 79.7 and 79.9 %, respectively, AD from VD are 74.5 and 72.4 %, AD from DLB are 70.2 and 76.2 %, and AD from NC are 76.1 and 85.4 %. SPECT does have diagnostic value, particularly in differentiating Alzheimer's disease from frontotemporal dementia and normal controls; however, it should not be used in isolation, rather as an adjunct, and interpreted in the context of clinical information and paraclinical test results.
Article
Purpose: The aim of this study is to assess the specific patterns of regional cerebral blood flow (rCBF) in patients with the early stage of subcortical vascular dementia (SVaD) and Alzheimer's disease (AD) using Tc-99m HMPAO SPECT, and to compare the differences between the two conditions. Materials and Methods: Sixteen SVaD, 46 AD and 12 control subjects participated in this study. We included the patients with SVaD and AD according to NINCDS-ADRDA and NINDS-AIREN criteria. They were all matched for age, education and clinical dementia rating scores. Three groups were evaluated by Tc-99m HMPAO SPECT using statistical parametric mapping (SPM) for measuring rCBF. The SPECT data of patients with SVaD and AD were compared with those of normal control subjects and then compared with each other. Results: SPM analysis of the SPECT image showed significant perfusion deficits on the right temporal region and thalamus, left insula and superior temporal gyrus, both cingulate gyri and frontal subgyri in patients with SVaD and on the left supramarginal gyrus, superior temporal gyrus, postcentral gyrus and inferior parietal lobule, right fugiform gyrus and both cingulate gyri in AD compared with control subjects (uncorrected p
Article
Accurate and early diagnosis of Alzheimer's Disease (AD) with reliable and noninvasive methods is of great importance for clinical practice as effective and specific antidementive therapies become available. The aim of the study was to evaluate the clinical relevance of event-related P300 in the early diagnosis of AD. Thirty patients with AD, 26 patients with mild cognitive impairment (MCI) from our Memory Clinic and 26 age-matched healthy controls (HC) were studied with event-related P300 potentials. Amplitudes of temporo-basal dipoles (TB-P300) were significantly diminished in AD compared to HC and MCI. Furthermore, latencies of temporo-superior dipoles (TS-P300) were significantly prolonged in AD compared with HC. Sensitivity was 90.0% for the differentiation of patients with AD from HC (specificity 79.1%) using reduced TB-P300 amplitudes and prolonged TS-P300 latencies. Similar results were found using Pz amplitudes as well as Fz latencies. Our data suggest that TB-P300 amplitudes and TS-P300 latencies may be an accurate clinically available, nonexpensive, noninvasive, and reliable marker for AD.
Article
Full-text available
Alzheimer's disease (AD) is one of the most devastating and cosily disorders affecting the aging population. Structural imaging (computed tomography [CT] and magnetic resonance imaging [MRI]) and functional imaging (single photon emission computed tomography [SPECT] and positron emission tomography [PET]) have been evaluated for their roles in the imaqinq diagnosis of AD. We have reviewed the recent literature to determine the capabilities of these neuroimaging techniques in comparison to current standards of clinical diagnosis. Our results indicate that there is wide variability in the accuracy of clinical assessments, in contrast to a more limited ranqe of variability of the accuracy of neuroimaqinq measurements. These results suggest that neuroimaging may serve an adjunctive role in raising this lower bound of diagnostic accuracy. Furthermore, we suggest that neuroimaging should be considered: (I) when clinical expertise is insufficient; (il) as a complement to specific likelihood ratios; and (iii) in specific types of patients, for whom clinical evaluation is inappropriate or inadequate.
Article
This study examined the influence of linearization correction (LC) on brain perfusion single-photon emission computed tomography (SPECT) for the diagnosis of Alzheimer's disease (AD). The early onset group (<65 years old) consisted of 10 patients with AD, and the late onset group (>/=65 years old) of 13 patients with AD. Age-matched controls included seven younger and seven older normal volunteers. Tc-99m hexamethyl propyleneamine oxine (HMPAO) SPECT images were reconstructed with or without LC [LC (+) or LC (-)] and a statistical analysis was performed using a three-dimensional stereotactic surface projection (3D-SSP). In addition, a fully automatic diagnostic system was developed, which calculated the proportion of the number of abnormal pixels in the superior and inferior parietal lobule, as well as in the precuneus and posterior cingulate gyrus. The areas under the receiver-operating characteristic curve (AUCs) of the early onset group for conventional axial SPECT images, SPECT + 3D-SSP images and the fully automatic diagnostic system were 0.71, 0.88, and 0.92 in LC (-) and 0.67, 0.85, and 0.91 in LC (+), respectively. The AUCs of the late onset group were 0.50, 0.61, and 0.79 in LC (-) and 0.49, 0.67, and 0.85 in LC (+), respectively. LC on Tc-99m HMPAO SPECT did not significantly influence the diagnostic performance for differentiating between AD and normal controls in either early or late onset AD. Further examination with individuals suffering from very mild dementia is, therefore, expected to elucidate the effect of LC on minimally hypoperfused areas.
Article
This paper reviews the use of neuroimaging in the diagnosis of dementia, especially Alzheimer's disease. Computed tomography is still used to determine reversible causes of dementia; however, without clinical symptoms these causes are hard to find and computed tomography scanning is only cost-effective in a defined group of patients. Using magnetic resonance imaging, atrophy of the medial temporal lobe can be assessed volumetrically and visually, with a high correlation between the two methods. Medial temporal lobe atrophy is highly predictive of Alzheimer's disease, and correlates with neuropsychological performance and postmortem histologically measured volume. Cerebral volume changes over time seem to differentiate Alzheimer's disease and mild cognitive impairment progressing to Alzheimer's disease from controls with high accuracy. Studies of the corpus callosum in dementia indicate a cortico-cortical disconnection caused by atrophy. Of the new techniques, functional magnetic resonance imaging seems the most promising. This technique can possibly play a role in predicting Alzheimer's disease in patients with mild cognitive impairment. The use of single-photon emission computed tomography and positron emission tomography in (early) differential diagnoses seems limited. Lower regional cerebral blood flow is related to the severity of dementia and survival. Iodine-123 iodobenzamide single-photon emission computed tomography in dementia with Lewy bodies seems promising. Current and future positron emission tomography studies concentrate on memory function and receptor imaging. The focus in neuroimaging, especially magnetic resonance imaging, has shifted to early diagnosis and monitoring of the disease course, with a special interest in predicting dementia in patients with mild cognitive impairment.
Article
To facilitate the diagnostic process for dementia. Five guidelines and four consensus statements on specific diagnostic recommendations, specialist referral recommendations, and costs of recommended diagnostic procedures were compared and summarized. A MEDLINE search from 1984 to 1999 and queries to experts yielded 14 guidelines and consensus statements that addressed the diagnosis of dementia. Only nine documents which had national or international scopes were reviewed. Comparisons were made on the specific diagnostic criteria for patient history, clinical examination, functional assessment, laboratory tests, neuroimaging, and other diagnostic tests, as well as specialist referral recommendations and costs for the recommended diagnostic procedures. The first three authors reviewed independently each document and completed a table on specific recommendations in each document. To settle disagreements about specific recommendations, they discussed them until they reached a consensus. To interpret the intent of vague statements, they used their best judgment. The documents differed in content, recommendations, and development methodology. They were based on either expert opinion or scientific evidence, or both. Although the nine documents were nearly unanimous in several recommendations, including assessing the presenting problem, taking a medical history, conducting physical and neurological examinations, and assessing the patient's mental and cognitive status, considerable differences in recommendations were common. Such differences led to large differentials in the estimated costs (range, 190to190 to 2,001) for recommended diagnostic assessments. A systematic approach to diagnostic recommendations for dementia may induce greater consistency among guidelines and consensus statements. The current approach leads to considerable variability in recommendations and estimated costs.
Article
Zusammenfassung Ziel der vorliegenden Untersuchung war es, zu prüfen, ob die HMPAO-SPECT zur Differenzierung zwischen der Demenz vom Alzheimer-Typ (DAT) und der Major Depression (MD) beitragen kann. Es wurden ECT-Befunde von 77 Patienten mit Gedächtnisstörungen beurteilt, davon hatten 48 eine DAT und 29 eine MD. Zunächst wurden die Defekte in der SPECT einer Hirn-Region zugeordnet und der Grad der Ausprägung (-1/-2/-3) bewertet. Anschließend wurden die einzelnen Befunde in eine von 7 Befundkategorien eingeordnet. In einigen dieser 7 Gruppen ergaben sich deutliche Häufungen der Fälle mit DAT bzw. MD. 35% aller DAT-Patienten wiesen bilaterale Defekte mit deutlicher (>-1) parietaler/parietotemporaler Minderperfusion auf, dagegen zeigte kein Patient mit MD dieses Muster. Unilaterale Defekte wiesen 62% der MD-, aber nur 31% der DAT-Patienten auf. Die Untersuchung zeigt, daß nur 35% der Patienten mit DAT das bislang als »pathognomonisch« bezeichnete Befundmuster aufwiesen. Dieses Perfusionsmuster kann aber - wenn es vorliegt - als sicheres Kriterium zur Abgrenzung gegen eine MD gewertet werden. Darüber hinaus lassen sich keine eindeutigen (»krankheitstypischen«) Perfusionsmuster erkennen, wenngleich unilaterale Defekte mehr auf eine MD hindeuten.
Article
Today Alzheimer's disease can be diagnosed with great accuracy and specificity by general practicioners. Dementia, however, is commonly diagnosed at the time of major domestic breakdown, when symptoms are severe, and family and community patience have been etoded. The terra dementia does not imply a specific cause or pathological process. More than 50 illnesses can cause dementia. Alzheimer's disease counts for the majority of cases, either alone or in combination with other illnesses, and therefore gains important medical and socioeconomical significance. The still unresolved aetiology of the neurodegenerative disorder is currently a matter of intensive clinical and basic research efforts worldwide. Neurobiological data set the conceptual basis for new promising treatment strategies. Currently, clinical therapy trials with acetylcholinesterase inhibitors have demonstrated efficacy regarding cognitive core symtoms in mildly to moderately demented patients. In order to encourage early referral and identification of patients, cooperation between memory clinics and specialized clinical psychogeriatric departments can provide services for patients with cognitive impairment and their caregivers, especially valuable for general practitioners, internists, psychiatrists and neurologists, offering a multidisciplinary assessment, early diagnosis, differential diagnosis, therapy and planning of an individual "care-package" for each patient. Early diagnosis enables the development of an individual plan of care, existing drug treatment can be rationalised, and appropriate treatment started at a stage when it is potentially of most value.
Article
[18F]Fluorodeoxyglucose scans were performed on 9 patients with Parkinson's disease and 14 normal subjects. Five patients were restudied after an interval of 3 to 4 years. We found no selective metabolic change in striatum, where dopamine deficit is known to be greatest, in affected patients; cerebral glucose metabolism was reduced uniformly throughout the parkinsonian brain (average 18% decrease). With increased severity of bradykinesia and the development of mild to moderate dementia, global brain metabolism in Parkinson's disease decreased further. In one moderately demented patient with Parkinson's disease, severe parietal cortex hypometabolism was found, similar to that seen in Alzheimer's disease. In contrast, mildly to moderately demented patients with Huntington's disease have marked caudate hypometabolism, but cerebral glucose metabolism is normal elsewhere. It appears that in addition to the wellknown neurotransmitter loss in the nigrostriatal system, there is an abnormal metabolic process involving neurons throughout the parkinsonian brain.
Article
Regional cerebral perfusion was evaluated by single photon emission computed tomography (SPET) using technetium 99m hexamethylpropylene amine oxime (99mTc-HMPAO) as a tracer, in 13 control subjects and 44 age-matched patients suffering from dementia of the Alzheimer's type (DAT, n=19), presumed Pick's disease (n=5), idiopathic Parkinson's disease with dementia (DPD, n=15) and progressive supranuclear palsy (PSP, n=5). HMPAO uptake was measured in the superior frontal, inferior frontal, parietal, temporal and occipital cortices, and the perfusion values were expressed as cortical/cerebellar activity ratios. As compared with controls, tracer uptake ratios in the DAT group were significantly reduced over all cortical regions, with the largest defects in the parieto-temporal and superior frontal cortices. A marked hypoperfusion affecting the superior and inferior frontal cortices was found in Pick's disease, whereas a mild but significant hypoperfusion was observed only in the superior frontal cortex of patients with PSP. In the DPD group, HMPAO uptake was significantly reduced in the parietal, temporal and occipital cortices, but not in the frontal cortex. These results show that DAT and DPD share an opposite anteroposterior HMPAO uptake defect as compared with the Pick's and PSP groups.
Article
Positron emission tomography (PET) with fluorodeoxyglucose (FDG), magnetic resonance imaging (MRI), and CT were carried out in a patient with Alzheimer's disease 16 months before he died. At autopsy, the gross appearance of the brain correlated with MRI and CT, which showed some regional atrophy. These were much less revealing than PET, which correlated with microscopic findings of neuronal loss and proliferation of glia. In areas of moderately impaired local cerebral metabolic rate of glucose, as revealed by reduced FDG uptake, there was some gliosis, primarily around the numerous senile plaques. In areas of severe metabolic impairment, there was a profound loss of neurons, extensive gliosis, and a diminished appearance of plaques. PET-FDG is a better measure of the severity of Alzheimer's disease than MRI or CT, because it reflects the degree of neuronal pathology.